Prothrombin Gene Mutation (Factor II Mutation)
An inherited gene change that mildly raises the risk of blood clots
Quick Facts
- Type: Inherited clotting tendency (thrombophilia)
- Gene involved: Prothrombin (factor II)
- Main risk: Venous blood clots
- Severity: Usually a mild increase in risk
Overview
The prothrombin gene mutation, also called the prothrombin G20210A or factor II mutation, is an inherited change in the gene that makes prothrombin, one of the proteins the body uses to form blood clots. The mutation leads to slightly higher than normal levels of prothrombin, which tips the balance toward clotting and increases the chance of developing abnormal blood clots, mainly in the veins.
This is one of the most common inherited clotting tendencies, known together as thrombophilias. Importantly, most people who carry the mutation never have a blood clot. It usually raises risk only modestly, and clots tend to occur when other risk factors are also present, such as surgery, pregnancy, or certain medications. Knowing about the mutation helps guide prevention during higher-risk situations.
Symptoms
The mutation itself causes no symptoms. Symptoms only appear if a blood clot forms. The most common clots are in the deep veins of the legs and in the lungs. Warning signs include:
- Swelling, pain, tenderness, redness, or warmth in one leg (possible deep vein thrombosis)
- Sudden shortness of breath, chest pain that worsens with breathing, or coughing up blood (possible pulmonary embolism, a medical emergency)
- Less commonly, clots in other veins
Because there are no day-to-day signs, the mutation is often discovered only after a clot or through family testing.
Causes
The condition is caused by a specific inherited change in the prothrombin gene.
- Genetic change: The G20210A variant increases the amount of prothrombin in the blood, promoting clot formation.
- Inheritance: The variant is passed down in families. Carrying one copy causes a small increase in risk; carrying two copies (less common) raises it more.
The mutation does not change over a lifetime, but the actual risk of a clot depends on the combination of this tendency with other situational risk factors.
Risk Factors
In carriers, the chance of a clot rises when other clotting risks are added, including:
- Surgery, injury, or prolonged immobility such as long travel or hospital stays
- Pregnancy and the weeks after childbirth
- Estrogen-containing birth control or hormone therapy
- Having another inherited clotting disorder, such as factor V Leiden
- Obesity, smoking, and older age
Diagnosis
The prothrombin mutation is identified with a blood test, usually prompted by a clot at a young age, an unexplained clot, recurrent clots, or a family history.
- Genetic test: A blood sample is analyzed for the prothrombin G20210A variant.
- Broader clotting workup: Doctors may test for other inherited clotting conditions at the same time.
- Family testing: Relatives may be offered testing if the mutation is found, guided by a specialist.
Treatment
Treatment focuses on preventing and managing clots rather than the gene itself.
- No clot: Many carriers need no daily medication. Preventive blood thinners may be used temporarily during high-risk times such as surgery, hospital stays, or after childbirth.
- Active clot: Blood-thinning (anticoagulant) medicine treats the clot and prevents it from growing or spreading, usually for several months.
- Recurrent clots: Longer-term anticoagulation may be considered, weighing the benefit against bleeding risk.
- Lifestyle and counseling: Addressing other risk factors and discussing safe contraception and pregnancy planning.
A specialist tailors the plan to the individual and their overall risk profile.
Prevention
- Inform your healthcare providers of the mutation before surgery, hospitalization, or pregnancy
- Stay active and hydrated, and move around during long journeys
- Discuss non-estrogen contraception options with your doctor
- Avoid smoking and maintain a healthy weight
- Learn the warning signs of a clot and seek help promptly if they occur
When to See a Doctor
Talk with a healthcare provider if you or close relatives have had blood clots, particularly at a young age or without a clear cause, so testing and prevention can be discussed. Seek emergency care right away for warning signs of a clot, such as swelling, pain, or redness in one leg, or sudden shortness of breath, chest pain, or coughing up blood, which can signal a clot in the lungs and is a life-threatening emergency.
Frequently Asked Questions
What is the prothrombin gene mutation?
It is an inherited change in the prothrombin (factor II) gene that raises the level of a clotting protein in the blood. This tips the balance toward clotting and modestly increases the risk of blood clots, mainly in the veins.
If I have the mutation, will I definitely get a blood clot?
No. Most carriers never have a clot. The mutation usually raises risk only modestly, and clots tend to occur when other factors are present, such as surgery, immobility, pregnancy, or estrogen-containing medicines.
How is the prothrombin mutation treated?
Many carriers without clots need no daily medicine but may use preventive blood thinners during high-risk periods. If a clot occurs, anticoagulant medication treats it, and longer-term treatment is considered for recurrent clots, guided by a specialist.
Should my family be tested?
Testing relatives is sometimes offered after the mutation is found, especially if there is a history of clots, but it is an individual decision best made with a specialist. Knowing the result can guide prevention during high-risk situations.
References
- MedlinePlus, U.S. National Library of Medicine. Prothrombin thrombophilia.
- National Heart, Lung, and Blood Institute (NHLBI). Venous Thromboembolism.
- National Blood Clot Alliance. Inherited clotting disorders.